Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study

Condition:

Category: General

Date: Aug 2016

Author: Revital Amiaz

Type: Article

This study speculated that augmentation of serotonin re-uptake inhibitors (SRIs) with naltrexone would improve obsessive-compulsive symptoms in OCD patients who had not responded or not fully responded to SRI treatment alone.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Not Finding What You're Looking For?

Fill out the form below to let us know.

>